ARVINAS, INC.

Profile

Company Names

ARVINAS, INC.
ARVINAS HOLDING COMPANY, LLC

Addresses

395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT 06511

395 WINCHESTER AVENUE, 5 SCIENCE PARK, NEW HAVEN, CT 06511

Phone Numbers

203-535-1456

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$129,109,995.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-07-16 
$32,499,996.00 
$32,499,996.00 
$0.00 
Equity 
2
2018-03-29 
$55,000,000.00 
$55,000,000.00 
$0.00 
Equity 
1
2015-10-16 
$41,609,999.00 
$41,609,999.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SEAN 
 
CASSIDY 
EXECUTIVE OFFICER
ARVINAS HOLDING COMPANY, LLC   |  ARVINAS, INC.   |  MEGAPORT LTD   |  LUCEM HEALTH, INC.   |  ABBRATECH HOLDINGS LLC   |  AUTOMERA US INC.   |  QUARRY DAC, INC   |  DURACRIN, LLC   |  QUARRY HEME, INC
JOHN 
D. 
HOUSTON 
EXECUTIVE OFFICER, DIRECTOR
ARVINAS HOLDING COMPANY, LLC
JOHN 
G. 
HOUSTON 
EXECUTIVE OFFICER, DIRECTOR
ARVINAS, INC.   |  NEXTCURE, INC.
EDWARD 
 
KENNEDY, JR. 
DIRECTOR
ARVINAS, INC.
ANDREW 
 
LEVIN 
DIRECTOR
IMMUNETICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  SYNTHORX, INC.   |  CLEANBREAK, INC.   |  CLEAR CREEK BIO, INC.   |  IMBRIA PHARMACEUTICALS, INC.   |  ELIEM THERAPEUTICS, INC.   |  ATHENEN THERAPEUTICS, INC.   |  ARCUATE THERAPEUTICS, INC.   |  AEROVATE THERAPEUTICS, INC.   |  SANTI THERAPEUTICS, INC.   |  CYTEK BIOSCIENCES, INC.   |  METAGENOMI TECHNOLOGIES, LLC   |  LUSARIS THERAPEUTICS, INC.   |  SUPERLUMINAL MEDICINES, INC.   |  NAVIGATOR MEDICINES, INC.   |  AKTIS ONCOLOGY, INC.   |  PAHR THERAPEUTICS, INC.   |  LONESTAR MEDICINES, INC.   |  SOLSTICE ONCOLOGY, INC.   |  SLATE MEDICINES, INC.   |  CLIMB BIO, INC.
MANUEL 
 
LITCHMAN 
EXECUTIVE OFFICER, DIRECTOR
ARVINAS HOLDING COMPANY, LLC
JAKOB 
 
LOVEN 
DIRECTOR
ARVINAS HOLDING COMPANY, LLC   |  VIVIDION THERAPEUTICS, INC.   |  ARRAKIS THERAPEUTICS, INC.   |  ARVINAS, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  ICONOVIR BIO, INC.   |  HEXAGON BIO INC.
BRAD 
 
MARGUS 
DIRECTOR
ARVINAS HOLDING COMPANY, LLC   |  NEURONA THERAPEUTICS, INC   |  HC BIOSCIENCE, INC.
BRADLEY 
 
MARGUS 
DIRECTOR
ARVINAS, INC.   |  MINDIMMUNE THERAPEUTICS, INC.
BRIGGS 
 
MORRISON 
DIRECTOR
ONCORUS, INC.   |  RIFT BIOTHERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ARVINAS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  CARISMA THERAPEUTICS INC.   |  CROSSBOW THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  CHARM THERAPEUTICS INC.
KUSH 
 
PARMAR 
DIRECTOR
ARVINAS, INC.   |  SCPHARMACEUTICALS INC.   |  AUDENTES THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  HOMOLOGY MEDICINES, INC.   |  5AM VENTURES V, L.P.   |  CYCLOPORTERS, INC.   |  AKOUOS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  RALLYBIO HOLDINGS, LLC   |  VOR BIOPHARMA INC.   |  ENSOMA, INC.
LIAM 
 
RATCLIFFE 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  NEURONETICS, INC.   |  UNUM THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEW LEAF GROWTH FUND I, L.P.   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  ARVINAS, INC.   |  ELIEM THERAPEUTICS, INC.   |  HALDA THERAPEUTICS, LLC
TIM 
 
SHANNON 
DIRECTOR
NOVIRA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  CYTOMX THERAPEUTICS, INC.   |  VIVACE THERAPEUTICS, INC.   |  SPYRYX BIOSCIENCES, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEXTCURE, INC.   |  HALDA THERAPEUTICS, LLC   |  RALLYBIO HOLDINGS, LLC   |  CAPITAL INTEGRATION SYSTEMS LLC   |  AER THERAPEUTICS, INC.
TIMOTHY 
 
SHANNON 
DIRECTOR
TRAXIS EMERGING MARKETS EQUITY OFFSHORE FUND LTD.   |  TRAXIS EMERGING MARKETS OPPORTUNITIES OFFSHORE FUND LTD.   |  HELIX THERAPEUTICS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  ALDEA PHARMACEUTICALS, INC.   |  VAXINNATE CORP   |  CORNOVUS PHARMACEUTICALS INC.   |  IDEAYA BIOSCIENCES, INC.   |  ARVINAS, INC.   |  INIVATA LTD   |  SIDUMA THERAPEUTICS, INC.   |  NORMUNITY HOLDING COMPANY, LLC   |  LAND MEDICINE INC.   |  TRITON THERAPEUTICS, INC.   |  QUARRY GLUE HOLDING CO LLC
JONATHAN 
 
SODERSTROM 
DIRECTOR
PHYTOCEUTICA, INC.   |  ARVINAS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  ARTIZAN BIOSCIENCES, INC.
STEPHEN 
 
SQUINTO 
DIRECTOR
UCAN CO   |  COMPASS THERAPEUTICS LLC   |  ARVINAS HOLDING COMPANY, LLC   |  SPRINGWORKS THERAPEUTICS, LLC   |  SPRINGWORKS THERAPEUTICS, INC.   |  PASSAGE BIO, INC.   |  GENNAO BIO, INC.   |  VANQUA BIO, INC.   |  EXSILIO THERAPEUTICS INC.   |  ENLAZA THERAPEUTICS, INC.   |  AVERNA THERAPEUTICS INC.
IAN 
 
TAYLOR 
EXECUTIVE OFFICER
ARVINAS, INC.   |  SIMBA CHAIN, INC.   |  MARKAI, INC.   |  EVOLVEIMMUNE THERAPEUTICS HOLDING COMPANY, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-07-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-07-16 
2018-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-29 
2015-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#